.Resource manager TPG, which has actually assisted biotechs such as Sionna Therapeutics and also San...
.Merck & Co.'s TIGIT course has experienced yet another trouble. Months after shuttering a period...
.After a year defined by pipe cuts, the shift of its CEO and discharges, Exscientia is going to merg...
.Cullinan Therapeutics was actually wowed enough with Port BioMed's bispecific immune activator that...
.Within this week's incident of "The Top Line," we're diving into Fierce Biotech's annual Fierce 15 ...
.The confetti is actually still soaring coming from Eli Lilly's event celebrating the commendation o...
.Accept to today's Chutes & Ladders, our roundup of notable management hirings, shootings and als...
.Following an inadequate presenting for Lykos Therapies' MDMA candidate for trauma at a current FDA ...
.AN2 Rehabs is reconsidering its own organization in reaction to uninspired midphase records, vowing...
.Merck & Co. is paying out $700 thousand upfront to challenge Amgen in a blood stream cancer cell...